Don't wait till doomsday. Potassium Iodide is used in the face of a nuclear emergency to save lives. When taking potassium iodide, time is crucial. Potassium iodide must be taken 1 hour in advance or within 4 hours of radiation exposure in order to be effective. Therefore potassium iodide is needed on-hand prior to a radioactive nuclear emergency. Potassium iodide is a specific blocker of thyroid radio-iodine uptake. An emergency supply of Potassium Iodide is the most important, safe and effective emergency nuclear radiation protection for individuals, families and communities.
Represent fashionably with original art concepts. Made to last just like America. Choose from many of our high quality, life time, machine washable designs.
Meant to be worn and shown off! Let's use fashion, to create a more aware, and health-orientated culture.
|»||Men's Sweatshirts / Outerwear||
|»||Women's Sweatshirts / Outerwear||
|»||Hats & Accessories||
|»||Undergarments and Pajamas||
|»||Bags & Wallets||
|»||Cases & Covers||
A small cup of coffee
Espresso in a glass
Espresso in glass
cups - 2 half cups
Another cup of
Espresso (a double)
Hot Vietnamese coffee w/condensed milk -
Cà phê sữa
Vietnamese milk coffee iced (Cà phê sữa đá)
Café au lait
Café au lait & begniets, Café du Monde
German "Kaffee mit Sahne"
Cup of Coffee w/Foam
Cup of Coffee w/Spices
Cup of Coffee with Whipped Cream
Wiener Melange - Half espresso, half hot frothy milk
Cappuccino with a "leaf" poured into it (latte art)
Another example of latte art
French "petit noir"
Café frappé in a glass
Milchkaffee, Café au lait
fresh coffee with Hungarian hand made painted cup
NO-RAD-ZONE magazine: Scientific Information with Summaries, News, Reports, Top 10 List, Product Reviews, Insider Information, Links + Events.
View This Issue
What are the Benefits of coffee?
People often wonder, "Is coffee good for you?"
Besides helping you get up in the morning, its healthy!
Scientific studies have found that there are a multitude of benefits to coffee.
Those who drink the most coffee substantially reduce the risk of developing diabetes, cancer, liver disease, cognitive decline, and DNA damage.
The health benefits of coffee's phytochemistry doesn't end there!
In this easy to digest report you will learn about recent research into the benefits of coffee, what's missing from your coffee beans, and how you can achieve these healthy benefits with one very smart cup of coffee.
You need to know that early studies are reporting an association between higher coffee consumption and a reduced risk of various cancers. Every morning many of us wake up to a cup of coffee with no real thought to the beans behind the brew. Coffee beans are extra ordinarily complex fruits, containing over 1,000 [1,2] compounds, only a handful of which have been individually investigated by scientist. Not only is coffee packed with antioxidants, but it is the greatest source of antioxidant in the american diet.[3,4]
The average american coffee drinker consumes 3.1 cups of coffee a day, but extensive research has found that higher volumes - as much as 4 to 12 cups daily - can help prevent most major killers including cardiovascular,[6-8] cancer,[9-11] diabetes, [12-14] liver disease, [15-17] and Alzheimer's disease.[18-20]
Coffee health is a real thing scientist have been studying for a long time. Coffee and Health go hand in hand and you don't have to go far to learn more about the benefits of coffee.
Coffee benefits come from over 1000 compounds that make up coffee's complex phytochemistry. Their documented protection against diabetes, Alzheimer's disease, cancer and a host of other chronic diseases may be due to an intricate web of chemically induced actions along various biological pathways.
DNA damage is characterize as a physical abnormality within the genetic makeup of a cell, such as a break in a DNA. It usually occurs to greater extent within cells that frequently divide. DNA damage can lead to genetic mutations that cause cancer. And when DNA damage occurs within cell that divide less frequently , it can promote aging.
It's difficult to avoid the many causes of DNA injury. Oxidizing agents produced by normal metabolic processes promote this kind of damage. Also, DNA defects can be triggered by numerous external agents such as ultraviolet light, radiation, chemotherapy, industrial chemicals, and certain environmental polycyclic hydrocarbons, found in smoke.
Scientists have discovered a surprisingly simple way to help decrease DNA damage. Studies show that higher coffee consumption decreases level of oxidative DNA damage,[90,91] which in turn inhibits both cancer and aging.
A 2011 study confirmed coffee's DNA-related effect on cancer risk. The researchers found that regular coffee enjoyed a 13% decreased risk of cancers generally, and those who consumed high levels of coffee enjoy a 18% decreased risk. Additionally, they enjoyed specific protection against prostate, breast, colorectal, pharyngeal, esophageal, hepatocellular, pancreatic, bladder, and endometrial cancers.
Despite coffee's powerful antioxidant punch, the mechanism for coffee's protection against a host of diseases may involve a lot more than a fierce battle between antioxidants and free radicals. Scientists are beginning to discover that coffee's phytochemistry also exerts direct biological actions on the body, which may underpin a web of indirect, protective effects against diseases from diabetes to cancer.93,94
Early studies suggest that the polyphenols in coffee (both caffeinated and decaffeinated) may modify key enzymes that improve intracellular signaling,95,96 the communication system that facilitates cellular actions such as tissue repair, immunity, and homeostasis. Poor cell signaling may be a factor in cancer, diabetes, and more. (A subsequent study suggested in 2008 that this cellular signaling effect could also explain coffee's inhibition of blood platelet aggregation and cardiovascular risk.97)
Then, in 2009, a study found that by modulating specific cell signaling pathways (known as ERK1/2 and JNK), the various polyphenols in coffee - especially chlorogenic acid - help prevent the degeneration of those human cells that are rich in lipids.98 Brain cells are lipid-rich and this may explain coffee's neuroprotective effect against cognitive decline and diseases of the brain.
Similarly, one study suggested that polyphenols - for which coffee is the prime dietary source - may affect cellular response and sensitivity by interacting with nuclear receptors.99 Receptors are molecules that pick up intracellular signals, determining whether a cell gets the right instructions to divide, die, or release molecules - thus regulating body functions to fight disease.
A 2006 review of animal and human studies found that coffee compounds raise levels of detoxifying enzymes that protect against DNA damage and - likely as a direct result - reduce the susceptibility of lymphocytes (white blood cells involved in immune response) to damage from reactive oxygen species (ROS).100 This may partly explain how coffee lowers the incidence of DNA damage and related diseases such as cancer.
One 2009 study on humans found that 3 cups of coffee daily for 3 weeks increased the number and metabolic activity of beneficial bacteria called bifidobacteria.101 These intestinal bacteria may explain one mechanism for coffee's benefits: bacteria can boost immunity, lower blood pressure, and increase mineral absorption.
In 2010, researchers discovered that the phenolics in 4-8 cups of coffee daily have the direct action of dampening inflammatory activity.66 Chronic low-level inflammation has been associated with diseases ranging from cancer to diabetes, as well as aging.
A 2011 randomized, controlled trial found that consumption of (caffeinated or decaffeinated) coffee produces specific improvements in the function of the liver and of adipocytes (fat-storing cells), both associated with a healthy metabolism. This provides further insight into the possible mechanisms behind coffee's benefits, because disrupted metabolic activity is a biological risk factor for a number of chronic diseases (including type 2 diabetes).102
In addition to the numerous other antioxidants in coffee, a 2011 study confirmed that caffeine itself is a potent scavenger of oxygenated free radicals.103 Caffeine was found in another 2011 study to work synergistically with other coffee antioxidants.104 However, caffeine may also work along direct cellular pathways unrelated to its antioxidant action.
Scientists determined in 2011 that caffeine protects the integrity of the blood-brain barrier - which suggests that caffeine may reduce the risk of some diseases by limiting the transport of blood-borne pathogens, drugs, cells, and other substances into the brain, where they might affect brain synapses. The team also found that caffeine defends against the specific blood-brain barrier dysfunction linked to Alzheimer's and Parkinson's disease.105
Alzheimer's disease becomes increasingly prevalent with aging, striking more than 40% of those over 84.72 Promising studies are finding that greater daily consumption of caffeinated coffee cuts the risk of both Alzheimer's18,73 and dementia74 later in life.
Scientists have discovered that long-term coffee intake exhibits a dose-dependent association with improved cognitive function and memory,75,76 and it protects primary neuronal cells.77
In fact, one mouse study has far-reaching implications for humans. Researchers found that moderate caffeine intake - equivalent to human consumption of 5 cups of coffee daily - began to reverse Alzheimer's damage in just 5 weeks.20
Although the mechanism by which coffee lowers the risk of cognitive decline is not known, a 2009 study on mice found that caffeine decreases levels, in both the blood and the brain, of amyloid-beta, a substance involved in the development of Alzheimer's.78 Later, a 2010 review of previous mouse studies found that caffeine - the equivalent of 5 cups of coffee daily in humans - decreases levels of beta- and gamma- secretase, proteins used in amyloid-beta production in the first place.20
Then, in 2011, scientists concluded that coffee may be the best source of the caffeine shown to protect against cognitive decline. The reason is that another unknown component in coffee appears to synergize with the caffeine to increase blood levels of a factor (granulocyte colony-stimulating factor, or GCSF) associated with improved cognitive function in Alzheimer's.79
Numerous studies show that higher daily coffee consumption results in a lower risk of diabetes, cardiovascular disease, cancer, Alzheimer's, and a host of other chronic diseases, including obesity.
There are a number of phytochemicals, the most predominate being chlorogenic acid, that provide coffee's disease-protecting punch. Of interest is the additional ability of coffee polyphenols to exert direct biological actions on cells. For instance, daily coffee intake may modify key enzymes that improve intracellular signaling,95,96 which can protect against diabetes, cancer, and many other diseases.
The benefit is dose-related. Drinking just one cup of coffee a day - caffeinated or decaffeinated - can decrease the risk of developing diabetes by 13%.24 But 12 cups a day slashes the risk of developing diabetes by 67%.21
While traditional medicine fights an impossible battle against a tidal wave of diabetes, cancer, Alzheimer's, and other age-related diseases, extensive research suggests that coffee - far from being a guilty pleasure that should be limited - is an all-natural and inexpensive elixir. With the availability of new "polyphenol-retaining" coffees, moderate coffee drinkers can now obtain the myriad benefits that were once reserved only for so-called "heavy" coffee users.
There remain, however, a significant percentage of people who are sensitive to caffeine's stimulating effects on the central nervous system, or find they encounter heartburn and other digestive problems in response to ingesting even a cup of coffee. The new polyphenol-retaining coffee bean beverages are less likely to induce gastric upset.
For those who don't want to drink any coffee, there are now standardized chlorogenic acid supplements available that provide the high potencies of beneficial coffee compounds with only tiny amounts of caffeine.
Discovering Coffee's Unique Health Benefits LE Mag January 2012.
1. Gold LS, Ames BN, Slone TH. Misconceptions about the causes of cancer. In: Paustenbach D, ed. Human and Environmental Risk Assessment: Theory and Practice. New York, NY: John Wiley & Sons; 2002:1415-60.
2. Available at: http://www.illy.com/wps/wcm/connect/us/illy/ the-world-of-coffee/the-science-of-coffee/. Accessed September 25, 2011.
3. Vinson JA. The potential health benefits of antioxidants. Presented at the 230th meeting of the American Chemical Society. August 28, 2005. Washington, DC.
4. Clifford MN. Chlorogenic acids and other cinnamates - nature, occurrence and dietary burden. J Sc Food Agric. 1999 Mar 1;79(3):362-72.
5. Available at: http://www.coffeeresearch.org/market/usa.htm. Accessed September 22, 2011.
6. Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr. 2006 May;83(5) 1039-46.
7. Wu J, Ho SC, Zhou C, et al. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol. 2009 Nov 12; 137(3):216-25.
8. Mukamal KJ, Hallqvist J, Hammar N, et al. Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program. Am Heart J. 2009 Mar;157(3):495-501.
9. Wilson KM, Kasperzyk JL, Rider JR. Coffee consumption and prostate cancer risk and progression in the health professionals follow-up study. J Natl Cancer Inst. 2011 Jun 8;103(11):876-84.
10. Li J, Seibold P, Chang-Claude J. Coffee consumption modifies risk of estrogen-receptor negative breast cancer. Breast Cancer Res. 2011 May 14;13(3):R49.
11. Inoue M, Yoshimi I, Sobue T, Tsugane S, JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: A prospective study in Japan. J Natl Cancer Inst. 2005 Feb;97(4):293-300.
12. Huxley R, Lee CM, Barzi F, et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med. 2009 Dec 14;169(22):2053-63.
13. Rosengren A, Dotevall A, Wilhelmsen L, Thelle D, Johansson S. Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study. J Intern Med. 2004 Jan;255(1):89-95.
14. Tuomilehto J, Hu G, Bidel S, Lindstrom J, Jousilahti P. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA. 2004 Mar 10;291(10):1213-9.
15. Corrao G, Zambon A, Bagnardi V, D'Amicis A, Klatsky A. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol. 2001 Oct;11(7):458-65.
16. Gallus S, Tavani A, Negri E, La Vecchia C. Does coffee protect against liver cirrhosis? Ann Epidemiol. 2002 Apr;12(3):202-5.
17. Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med. 2006 Jun 12;166(11):1190-5.
18. Maia L, de Mendonça A. Does caffeine intake protect from Alzheimer's disease? Eur J Neurol. 2002 Jul;9(4):377-82.
19. Butt MS, Sultan MT. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2011 Apr;51(4):363-73.
20. Arendash GW, Cao C. Caffeine and coffee as therapeutics against Alzheimer's disease. J Alzheimers Dis. 2010;20 Suppl 1:S117-26.
21. Zhang Y, Lee ET, Cowan LD, Fabsitz RR, Howard BV. Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: The Strong Heart Study. Nutr Metab Cardiovasc Dis. 2011 Jun;21(6):418-23.
22. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011 Jul 2;378(9785):31-40.
23. International Diabetes Federation. Presidential address ahead of New Diabetes Atlas, 5th Edition. Presented at European Association for the Study of Diabetes (EASD) 47th annual meeting. September 13, 2011. Lisbon, Portugal.
24. van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care. 2006 Feb;29(2):398-403.
25. Johnston KL, Clifford MN, Morgan LM. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr. 2003 Oct;78(4):728-33.
26. Hemmerle H, Burger HJ, Below P, et al. Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. J Med Chem. 1997 Jan 17;40(2):137-45.
27. Greer F, Hudson R, Ross R, Graham T. Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes 2001 Oct;50(10):2349-54.
28. Arnlov J, Vessby B, Riserus U. Coffee consumption and insulin sensitivity. JAMA. 2004 Mar 10;291(10):1199-201.
29. Fleming DJ, Jacques PF, Dallal GE, Tucker KL, Wilson PWF, Wood RJ. Dietary determinants of iron stores in a free-living elderly population: the Framingham Heart Study. Am J Clin Nutr 1998 Apr;67(4):722-33.
30. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently health women. JAMA. 2004 Feb 11;291(6):711-7.
31. Available at: http://www.cancer.org/acs/groups/cid/documents/webcontent/003134-pdf.pdf. Accessed October 9, 2011.
32. Loopstra-Masters RC, Liese AD, Haffner SM, Wagenknecht LE, Hanley AJ. Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function. Diabetologia. 2011 Feb;54(2):320-8.
33. Call R, Grimsley M, Cadwallader L, et al. Insulin - carcinogen or mitogen? Preclinical and clinical evidence from prostate, breast, pancreatic, and colorectal cancer research. Postgrad Med. 2010 May;122(3):158-65.
34. Available at: http://www.cancer.org/acs/groups/cid/documents/webcontent/003090-pdf.pdf. Accessed October 9, 2011.
35. Bageman E, Ingvar C, Rose C, Jernstrom H. Coffee consumption and CYP1A2 genotype modify age at breast cancer diagnosis and estrogen receptor status. Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):895-901.
36. Available at: http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/colorectal-cancer-key-statistics. Accessed October 9, 2011.
37. Galeone C, Turati F, La Vecchia C, Tavani A. Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control studies. Cancer Causes Control. 2010 Nov;21(11):1949-59.
38. Michels KB, Willett WC, Fuchs CS, Giovannucci E. Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J Natl Cancer Inst. 2005 Feb 16;97(4):282-92.
39. Giovannucci E. Meta-analysis of coffee consumption and risk of colorectal cancer. Am J Epidemiol. 1998;147(11):1043-52.
40. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S. Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. Int J Cancer. 2007 Jun 1;121(6):1312-8.
41. Oba S, Shimizu N, Nagata C, et al. The relationship between the consumption of meat, fat, and coffee and the risk of colon cancer: a prospective study in Japan. Cancer Lett. 2006;244(2):260-7.
42. Available at: http://www.cancer.org/Cancer/OralCavityand OropharyngealCancer/DetailedGuide/oral-cavity-and-oropharyngeal-cancer-key-statistics. Accessed October 9, 2011.
43. Tavani A, Bertuzzi M, Talamini R, et al. Coffee and tea intake and risk of oral, pharyngeal and esophageal cancer. Oral Oncol. 2003;39(7):695-700.
44. Rodriguez T, Rodriguez T, Altieri A, et al. Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol. 2004;40(2):207-13.
45. Available at: http://www.cancer.org/Cancer/LiverCancer/DetailedGuide/liver-cancer-what-is-key-statistics. Accessed October 10, 2011.
46. Shimazu T, Tsubono Y, Kuriyama S, et al. Coffee consumption and the risk of primary liver cancer: Pooled analysis of two prospective studies in Japan. Int J Cancer. 2005 Aug 10;116(1):150-4.
47. Ohfuji S, Fukushima W, Tanaka T, et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study. Hepatol Res. 2006 Nov;36(3):201-8.
48. Tanaka K, Hara M, Sakamoto T, et al. Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan. Cancer Sci. 2007 Feb;98(2):214-8.
49. Kurozawa Y, Ogimoto I, Shibata A, et al. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer. 2005 Sep 5;93(5):607-10.
50. Inoue M, Yoshimi I, Sobue T, Tsugane S. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst. 2005 Feb 16;97(4):293-300.
51. Montella M, Polesel J, La Vecchia C, et al. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer. 2007 Apr 1;120(7):1555-9.
52. Gallus S, Bertuzzi M, Tavani A, et al. Does coffee protect against hepatocellular carcinoma? Br J Cancer. 2002 Oct 21;87(9):956-9.
53. Available at: http://www.cdc.gov/nchs/fastats/lcod.htm. Accessed October 10, 2011.
54. Ochiai R, Chikama A, Kataoka K, et al. Effects of hydroxyhydroquinone-reduced coffee on vasoreactivity and blood pressure. Hypertens Res. 2009 Nov;32(11):969-74.
55. Zhang WL, Lopez-Garcia E, Li TY, Hu FB, van Dam RM. Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia. 2009 May;52(5):810-7.
56. Myers MG, Basinski A. Coffee and coronary heart disease. Arch Intern Med. 1992 Sep;152(9):1767-72.
57. Wu J, Ho SC, Zhou C, et al. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol. 2009 Nov 12;137(3):216-25.
58. Lopez-Garcia E, Rodriguez-Artalejo F, Rexrode KM, Logroscino G, Hu FB, van Dam RM. Coffee consumption and risk of stroke in women. Circulation. 2009 Mar 3;119(8):1116-23.
59. Hamer M. Coffee and health: explaining conflicting results in hypertension. J Hum Hypertens 2006 Dec;20(12):909-12.
60. George SE, Ramalakshmi K, Mohan Rao LJ. A perception on health benefits of coffee. Crit Rev Food Sci Nutr. 2008 May;48(5):464-86.
61. Lane JD, Pieper CF, Phillips-Bute BG, Bryant JE, Kuhn CM. Caffeine affects cardiovascular and neuroendocrine activation at work and home. Psychosom Med. 2002 Jul-Aug;64(4):595-603.
62. Ochiai R, Chikama A, Kataoka K, et al. Effects of hydroxyhydroquinone-reduced coffee on vasoreactivity and blood pressure. Hypertens Res. 2009 Nov;32(11):969-74.
63. Lopez-Garcia E, van Dam RM, Li TY, Rodriguez-Artalejo F, Hu FB. The relationship of coffee consumption with mortality. Ann Int Med. 2008 Jun 17;148(12):904-14.
64. Koizumi A, Mineharu Y, Wada Y, Iso H, et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. Journal of Epidemiology and Community Health. 2011 Mar;65(3):230-40.
65. Natella F, Nardini M, Belelli F, et al. Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. Brit J Nutr. 2008 Dec;100(6):1276-82.
66. Kempf K, Herder C, Erlund I, et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr. 2010 Apr;91(4):950-7.
67. van Woudenbergh GJ, Vliegenthart R, van Rooij FJ, et al. Coffee consumption and coronary calcification: the Rotterdam Coronary Calcification Study. Arterioscler Thromb Vasc Biol. 2008 May;28(5):1018-23.
68. Available at: http://emedicine.medscape.com/article/185856-overview. Accessed October 25, 2011.
69. Corrao G, Zambon A, Bagnardi V, D'Amicis A, Klatsky A. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol. 2001;11(7):458-65.
70. Klatsky AL, Armstrong MA, Friedman GD. Coffee, tea, and mortality. Ann Epidemiol. 1993 Jul;3(4):375-81.
71. Benoit S, Christophe C, Angelika T, Anne C. Health effects and safety considerations. In: Clark R, Vitzthum OG, eds. Coffee: Recent Developments. London, UK: Wiley-Blackwell; 2001;165-83.
72. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003 Aug;60(8):1119-22.
73. Lindsay J, Laurin D, Verreault R, et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian study of health and aging. Am J Epidemiol. 2002 Sep 1;156(5):445-53.
74. Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis. 2009;16(1):85-91.
75. Johnson-Kozlow M, Kritz-Silverstein D, Barrett-Connor E, Morton D. Coffee consumption and cognitive function among older adults. Am J Epidemiol. 2002 Nov 1;156(9):842-50.
76. Jarvis MJ. Does caffeine intake enhance absolute levels of cognitive performance? Psychopharmacology (Berl).1993;110 (1 - 2):45-52.
77. Chu Y-F, Brown PH, Lyle BJ, et al. Roasted coffees high in lipophilic antioxidants and chlorogenic acid lactones are more neuroprotective than green coffees. J Agric Food Chem. 2009 Oct 28;57(20):9801-8.
78. Cao C, Cirrito JR, Lin X. Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. J Alzheimers Dis. 2009;17(3):681-97.
79. Cao C, Wang L, Lin X, et al. Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice. J Alzheimers Dis. 2011;25(2):323-35.
80. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006 Jun;5(6):525-35.
81. Hu G, Bidel S, Jousilahti P, Antikainen R, Tuomilehto J. Coffee and tea consumption and the risk of Parkinson's disease. Mov Disord. 2007 Nov 15;22(15):2242-48.
82. Meuer K, Pitzer C, Teismann P, et al. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. J Neurochem. 2006 May;97(3):675-86.
83. Song S, Sava V, Rowe A, et al. Granulocyte-colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson's disease. Neurosci Lett. 2011 Jan 7;487(2):153-7.
84. Cao XQ, Arai H, Ren YR, et al. Recombinant human granulocyte colony-stimulating factor protects against MPTP-induced dopaminergic cell death in mice by altering Bcl-2/Bax expression levels. Neurochem. 2006 Nov;99(3):861-7.
85. Huang HY, Lin SZ, Kuo JS, Chen WF, Wang MJ. G-CSF protects dopaminergic neurons from 6-OHDA-induced toxicity via the ERK pathway. Neurobiol Aging. 2007 Aug;28(8):1258-69.
86. Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000 May 24-31;283(20):2674-9.
87. Benedetti MD, Bower JH, Maraganore DM, et al. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-controlled study. Neurology. 2000 Nov 14;55(9):1350-8.
88. Ascherio A, Zhang SM, Hernan MA, et al. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol. 2001 Jul;50(1):56-63.
89. Best BP. Nuclear DNA damage as a direct cause of aging. Rejuvenation Res. 2009;12(3):199-208.
90. Misik M, Hoelzl C, Wagner KH, et al. Impact of paper filtered coffee on oxidative DNA-damage: results of a clinical trial. Mutat Res. 2010 Oct 13;692(1-2):42-8.
91. Bakuradze T, Boehm N, Janzowski C, et al. Antioxidant-rich coffee reduces DNA damage, elevates glutathione status and contributes to weight control: results from an intervention study. Mol Nutr Food Res. 2011 May;55(5):793-7.
92. Yu X, Bao Z, Zou J, Dong J. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer. 2011 Mar 15;11:96.
93. van Dam, RM. Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl Physiol Nutr Metab. 2008 Dec;33(6):1269-83.
94. van Dam RM. Coffee and type 2 diabetes: from beans to beta-cells. Nutr Metab Cardiovasc Dis. 2006;16:69-77.
95. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med. 2004 Apr 1;36(7):838-49.
96. Virgili F, Marino M. Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity. Free Radic Biol Med. 2008 Nov 1;45(9):1205-16.
97. Natella F, Nardini M, Belelli F, et al. Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. Brit J Nutr 2008 Dec;100(6):1276-82.
98. ChuYF, Brown PH, Lyle BJ, et al. Roasted coffees high in lipophilic antioxidants and chlorogenic acid lactones are more neuroprotective than green coffees. J Agric Food Chem. 2009 Oct 28;57(20):9801-8.
99. Virgili F, Marino M. Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity. Free Radic Biol Med. 2008 Nov 1;45(9):1205-16.
100. Hoelzl C, Bichler J, Ferk F, et al. Mechanistic aspects of DNA - and cancer - protective effects of coffee. Presented at Association for Science and Information on Coffee. 2006. Montpellier, VT.
101. Jaquet M, Rochat I, Moulin J, Cavin C, Bibiloni R. Impact of coffee consumption on the gut microbiota: A human volunteer study. Int J Food Microbiol. 2009 Mar.;130(2):117-21.
102. Wedick NM, Brennan AM, Sun Q, Hu FB, Mantzoros CS, van Dam RM. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: A randomized controlled trial. Nutr J. 2011 Sep 13;10(1):93.
103. Leon-Carmona JR, Galano A. Is caffeine a good scavenger of oxygenated free radicals? J Phy Chem B. 2011;115(15):4538-46.
104. Cao C, Wang L, Lin X, et al. Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice. J Alzheimers Dis. 2011;25(2):323-35.
105. Chen X, Ghribi O, Geiger JD. Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's disease. J Alzheimers Dis. 2011 May 3;20(Suppl 1):S127-41.
106. US Patent Publication No. US2010/0183790 A1. Publication Date July 22, 2010. Method for Enhancing Post-Processing Content of Beneficial Compounds in Beverages Naturally Containing Same.
107. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med. 1998 Apr 1;128(7):534-40.
108. Leitzmann WF, Willett WC, Rimm EB, et al. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA. 1999 Jun;281(22):2106-12.
109. Leitzmann MF, Stampfer MJ, Willett WC, Spiegelman D, Colditz GA, Giovannucci EL. Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology. 2002 Dec;123(6):1823-30.
110. Thom E. The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people. J Int Med Res. 2007 Nov-Dec;35(6):900-8.
111. Greenberg JA, Boozer CN, Geliebter A. Coffee, diabetes, and weight control. Am J Clin Nutr. 2006;84:682-93.
112. Iwai N, Ohshiro H, Kurozawa Y, et al. Relationship between coffee and green tea consumption and all-cause mortality in a cohort of a rural Japanese population. J Epidemiol. 2002 May;12(3):191-8.
113. Murray SS, Bjelke E, Gibson RW, Schuman LM. Coffee consumption and mortality from ischemic heart disease and other causes: results from the Lutheran Brotherhood study, 1966-1978. Am J Epidemiol. 1981 Jun;113(6):661-7.
114. Jazbec A, Simic D, Corovic N, Durakovic Z, Pavlovic M. Impact of coffee and other selected factors on general mortality and mortality due to cardiovascular disease in Croatia. J Health Popul Nutr. 2003 Dec;21(4):332-40.
115. Rosengren A, Wilhelmsen L. Coffee, coronary heart disease and mortality in middle-aged Swedish men: findings from the Primary Prevention Study. J Intern Med. 1991 Jul;230(1):67-71.
116. Flinn S, Gregory J, McNaughton LR, Tristram S, Davies P. Caffeine ingestion prior to incremental cycling to exhaustion in recreational cyclists. Int J Sports Med. 1990 Jun;11(3):188-93.
117. Denadai BS, Denadai ML. Effects of caffeine on time to exhaustion in exercise performed below and above the anaerobic threshold. Braz J Med Biol Res. 1998 Apr;31(4):581-5.
118. Ryu S, Choi SK, Joung SS, et al. Caffeine as a lipolytic food component increases endurance performance in rats and athletes. J Nutr Sci Vitaminol. 2001 Apr;47(2):139-46.
119. Motl RW, O'Connor PJ, Tubandt L, Puetz T, Ely MR. Effect of caffeine on leg muscle pain during cycling exercise among females. Med Sci Sports Exerc. 2006 Mar;38(3):598-604.
120. Kivity S, Ben Ahron Y, Man A, Topilsky M. The effect of caffeine on exercise - induced bronchoconstriction. Chest. 1990 May;97(5):1083-5.
121 Lucas M, Mirzaei F, Pan A. Coffee, caffeine, and risk of depression among Women. Arch Intern Med. 2011 Sep 26;171(17):1571-8.
122. Ferrazzano GF, Amato I, Ingenito A, De Natale A, Pollio A. Anti-cariogenic effects of polyphenols from plant stimulant beverages (cocoa, coffee, tea). Fitoterapia. 2009 Jul;80(5):255-62.
123. Rao SS, Welcher K, Zimmerman B, Stumbo P. Is coffee a colonic stimulant? Eur J Gastroenterol Hepatol. 1998 Feb;10(2):113-8.
124. Brown SR, Cann PA, Read NW. Effect of coffee on distal colon function. Gut. 1990 Apr;31(4):450-3.
125. Armstrong LE, Casa DJ, Maresh CM, Ganio MS. Caffeine, fluid-electrolyte balance, temperature regulation, and exercise-heat tolerance. Exerc Sport Sci Rev. 2007 Jul;35(3):135-140.
126. Armstrong LE, Pumerantz AC, Roti MW, et al. Fluid, electrolyte, and renal indices of hydration during 11 days of controlled caffeine consumption. Int J Sport Nutr Exerc Metab. 2005 Jun;15(3):252-65.
127. Grandjean AC, Reimers KJ, Bannick KE, Haven MC. The effect of caffeinated, non-caffeinated, caloric and non-caloric beverages on hydration. J Am Coll Nutr. 2000 Oct;19(5):591-600.
128. Available at: http://www.webmd.com/content/article/46/1826_50681.htm. Accessed September 22, 2011.
129. Song F, et al. Coffee consumption associated with decreased risk for basal cell carcinoma. Presented at the 10th American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research. October 24, 2011. Boston, MA.